Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

ZANAFLEX Drug Profile

« Back to Dashboard

Which patents cover Zanaflex, and what substitute generic drugs are available?

Zanaflex is a drug marketed by Acorda and is included in two NDAs.

The generic ingredient in ZANAFLEX is tizanidine hydrochloride. There are eleven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the tizanidine hydrochloride profile page.

Summary for Tradename: ZANAFLEX

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list8
Bulk Api Vendors: see list32
Clinical Trials: see list3
Patent Applications: see list2,198
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZANAFLEX at DailyMed

Pharmacology for Tradename: ZANAFLEX

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acorda
ZANAFLEX
tizanidine hydrochloride
CAPSULE;ORAL021447-001Aug 29, 2002RXYesNo► Subscribe► Subscribe
Acorda
ZANAFLEX
tizanidine hydrochloride
TABLET;ORAL020397-002Feb 4, 2000DISCNYesNo► Subscribe► Subscribe
Acorda
ZANAFLEX
tizanidine hydrochloride
CAPSULE;ORAL021447-002Aug 29, 2002RXYesNo► Subscribe► Subscribe
Acorda
ZANAFLEX
tizanidine hydrochloride
CAPSULE;ORAL021447-003Aug 29, 2002RXYesYes► Subscribe► Subscribe
Acorda
ZANAFLEX
tizanidine hydrochloride
TABLET;ORAL020397-001Nov 27, 1996RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ZANAFLEX

Drugname Dosage Strength RLD Submissiondate
tizanidine hydrochlorideCapsules2 mg, 4 mg and 6 mgZanaflex8/10/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc